Microbiome Research Converges on Hidden Gut Bacteria, Infant Allergy Prevention, and Cancer Immunotherapy
A Cambridge-led study identifies CAG-170 bacteria as a global marker of gut health, Siolta Therapeutics reports a 64 percent reduction in infant atopic dermatitis risk, and UF Health isolates a bacterial metabolite that doubles lung cancer immunotherapy response in mice.
4 min read4 sources